BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Lumara Health (Formerly Known As KV Pharmaceutical) 

16640 Chesterfield Grove Road
Suite 200
Chesterfield  Missouri  63005  U.S.A.
Phone: 314-645-6600 Fax: 314-646-3705


SEARCH JOBS




Industry
Pharmaceutical






 Company News
AMAG Pharmaceuticals, Inc. (AMAG) Completes Acquisition Of Lumara Health's Maternal Health Business 11/13/2014 7:32:05 AM
Lumara Health To Sponsor 40 Weeks Documentary To Raise Awareness Of The Importance Of A Full-Term Pregnancy 11/6/2014 10:21:33 AM
Lumara Health Announces Recipients Of $75,000 In Grants To Fund Prematurity Prevention Research 10/28/2014 8:40:07 AM
AMAG Pharmaceuticals, Inc. (AMAG) Shells Out $675 Million For Women's Health Company Lumara Health 9/29/2014 6:14:41 AM
Warning Letter Resurrects Issue Of KV Pharmaceutical 's Makena 3/17/2014 7:31:04 AM
$12.8 Million Settlement Pending In KV Pharmaceutical Class-Action Suit 3/6/2014 7:57:49 AM
Still-Kicking KV Pharmaceutical Creates Two Divisions Under Reorganization 2/24/2014 7:53:12 AM
KV Pharmaceutical Clinical Study On Reducing The Risk Of Recurrent Preterm Birth Becomes Largest Of Its Kind 1/21/2014 10:46:27 AM
KV Pharmaceutical Completes New Board With Appointment of Former Johnson & Johnson (JNJ) Executive 11/5/2013 9:27:02 AM
KV Pharmaceutical Appoints Former Wyeth Research (New Jersey) (WYE) President, Joe Mahady to Chairman of the Board 10/3/2013 7:23:46 AM
123